Abbott received FDA approval for its innovative TactiCath Contact Force Ablation Catheter, Sensor Enabled. The device, cleared in Europe a couple of years ago, is used to ablate cardiac tissue as part of treatment for atrial fibrillation. It features a pressure sensor that provides feedback on the contact force applied to cardiac tissue, helping (Read more...)